Rose Piper
About Rose Piper
Rose Piper is a Senior Territory Business Manager specializing in Immunoscience at Bristol-Myers Squibb in New Jersey, United States.
Company
Rose Piper is currently employed at Bristol-Myers Squibb, a global biopharmaceutical company. She holds the position of Senior Territory Business Manager in the field of Immunoscience. The company is based in New Jersey, where Rose focuses her efforts on territory business management, contributing to Bristol-Myers Squibb's commitment to discovering, developing, and delivering innovative medicines.
Title
As a Senior Territory Business Manager in Immunoscience, Rose Piper holds a vital role at Bristol-Myers Squibb. Her responsibilities likely encompass overseeing sales and operations within her designated territory, identifying opportunities for growth, and fostering strong relationships with healthcare professionals to promote the company's immunoscience products.
Education and Expertise
Rose Piper obtained her Bachelor of Arts in History from The University of Kansas. Her academic background, combined with her extensive industry experience, has provided her with a well-rounded perspective essential for her role in the biopharmaceutical sector. Rose's specialization in Immunoscience contributes significantly to her proficiency in managing business operations and driving sales within this medical field.
Professional Experience
Rose Piper has been with Bristol-Myers Squibb for over 8 years, beginning her tenure with the company in January 2015. Throughout her career, she has focused on territory business management within the immunoscience division. Her role requires a deep understanding of the market, excellent communication skills, and the ability to implement strategic initiatives to enhance the company's presence in her territory.
Work Location
Rose Piper operates in the New Jersey area, where she manages her responsibilities as a Senior Territory Business Manager. Her work involves significant interaction with healthcare providers and stakeholders in the region, ensuring that Bristol-Myers Squibb's immunoscience products are effectively represented and that their therapeutic benefits are communicated clearly.